Skip to main content

Table 1 Hemodynamic and INVOS data

From: Intravenous levosimendan-norepinephrine combination during off-pump coronary artery bypass grafting in a hemodialysis patient with severe myocardial dysfunction

 

T1

T2

T3

T4

T5

T6

T7

T8

T9

T10

HR

60

62

64

64

61

64

65

66

63

68

Psyst

100

125

104

113

108

97

101

110

91

106

Pdiast

45

71

51

61

58

52

51

58

48

55

MAP

57

91

61

80

76

69

70

83

67

70

CVP

18

18

17

16

16

14

15

12

10

10

PAPsyst

56

48

46

46

44

44

40

39

31

35

PAPdiast

25

18

17

17

17

19

20

17

19

17

PAPmean

37

30

30

30

25

25

26

23

24

24

PAOP

 

18

17

16

16

16

16

16

16

15

CO

2.8

3.6

4.1

4.2

4.0

4.6

4.3

4.6

4.6

4.6

CI

1.6

2.1

2.4

2.4

2.0

2.7

2.5

2.7

2.7

2.7

SVR

1114

1622

858

1219

1200

956

1023

1234

991

1043

PVR

 

266

253

266

180

156

186

121

139

156

LVEF

25

  

40

40

     

SvO2

49

70

80

80

82

82

80

60

65

58

INVOSLeft

45

59

59

55

60

60

    

FiO2

0.5

0.5

0.5

0.5

0.5

0.6

0.6

0.4

0.4

0.21

Norepinephrine*

 

0.05

0.08

0.12

0.15

0.12

0.15

0.2

0.08

0.02

  1. * Dose in μg/kg/min
  2. HR in beats/minute
  3. Psyst, Pdiast, P mean, CVP, PAPsyst, PAPdiast, PAPmean, PCWP, all measured in mmHg
  4. CO = L/min, CI = L/m2/min SVO2 = %, INVOS = %
  5. T1 before levosimendan/norepinephrine infusion started
  6. T2 1 h after levosimendan infusion started
  7. T3, T4 2 and 3 hours after levosimendan infusion started
  8. T5 at end of surgery
  9. T6 T7 6 and 12 hours after surgery
  10. T8, T9, T10 18, 24, 36 hours after surgery
Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us